Gamgee YC 지원서

Summer 2026Active

San Francisco

Gamgee은(는) Summer 2026 배치에서 Healthcare 회사로 Y Combinator를 거쳤습니다. 아래에는 회사의 사업 내용, 창립자, 그리고 실제 YC 양식에 맞춰 재구성한 YC 지원서가 있습니다.

YC 배치: Summer 2026
산업: HealthcareDrug Discovery and Delivery
위치: San Francisco
팀 규모: 2
상태: Active
출시됨: 2026

창업자

Paul ConynghamFounder/CEO

Gamgee의 사업 내용

Gamgee began with Rosie, founder Paul Conyngham’s dog. After surgery, chemotherapy and immunotherapy failed, Rosie was given months to live. Paul used AI and genomic analysis to identify targets in her tumour, then worked with scientists at UNSW to produce what is believed to be the first fully computationally designed mRNA cancer vaccine delivered to a dog. Following treatment, several tumours shrank significantly and her quality of life improved Gamgee is building an end to end platform for personalised mRNA cancer vaccines for dogs. We sequence a dog’s tumour and healthy DNA, identify mutations unique to its cancer, and design a vaccine that teaches the immune system what to attack. We manage the entire process- from vet intake and tissue collection through genomic analysis, vaccine production, treatment and response monitoring We are now turning that one off effort into a repeatable clinical system. Gamgee is running clinical trials in Australia, working with vets, oncologists and specialised laboratories, and accepting cases globally. Our goal is to make personalised cancer treatment accessible to every dog that needs it- and use each case to improve the treatment for the next

Gamgee의 YC 지원서, 재구성됨

Y Combinator 지원

Gamgee, Summer 2026 기수. 공개 데이터를 기반으로 작성된 실제 지원 질문.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Gamgee

Describe what your company does in 50 characters or less.

Personalised mRNA cancer vaccines for dogs.

What is your company going to make? Please describe your product and what it does or will do.

We're building an end-to-end platform for personalised mRNA cancer vaccines for dogs. We start by sequencing a dog's tumour and normal tissue, then use AI to identify and rank tumour-specific mutations. Our platform designs a custom mRNA vaccine targeting these mutations, coordinates production, and works with vets to oversee treatment and monitor outcomes.

Where do you live now, and where would the company be based after YC?

San Francisco, CA, USA; Remote. The company would remain based there after YC.

Explain your decision regarding location.

San Francisco connects us to both biotech resources and the YC ecosystem. We operate remotely to collaborate with labs, vets, and trial sites in Australia and globally.

전체 지원서에서 21개의 추가 답변

Founders, Progress, Idea, Equity, Curious, Batch Preference는 전체 버전에 있습니다. 무료 계정을 만들어 YC Insights에서 모든 YC 배치 옆에 열어보세요.

전체 지원 보기

자주 묻는 질문

Gamgee의 실제 YC 지원서인가요?

아닙니다. Y Combinator는 제출된 지원서를 비공개로 유지합니다. 이것은 재구성된 것입니다. 실제 YC 양식 질문에 Gamgee의 공개 데이터(출시 노트, 창업자 배경, 제품 설명)를 기반으로 답변했습니다. Gamgee과 같은 회사가 YC에 어떻게 자신을 소개하는지 보여주며, 그들이 제출한 텍스트는 아닙니다.